Covered recipient · General Payments record
DARCY M REID
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$3,680.28
- Reported across 207 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $598.33 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $174.66 | 8 |
| Novo Nordisk AS | $140.23 | 7 |
| Amgen Inc. | $72.37 | 3 |
| PFIZER INC. | $66.15 | 3 |
| Acerta Pharma LLC | $37.46 | 2 |
| GlaxoSmithKline, LLC. | $29.78 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.28 | 1 |
| Otsuka America Pharmaceutical, Inc. | $26.65 | 1 |
| Lundbeck LLC | $21.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.55 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108072343 | CMS |
| ABBVIE INC. | $23.84 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108072345 | CMS |
| ABBVIE INC. | $21.96 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108072347 | CMS |
| ABBVIE INC. | $24.46 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108072349 | CMS |
| ABBVIE INC. | $28.89 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108072351 | CMS |
| ABBVIE INC. | $26.90 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108072353 | CMS |
| ABBVIE INC. | $6.80 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108072355 | CMS |
| ABBVIE INC. | $25.26 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108072357 | CMS |
| Amgen Inc. | $25.12 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117664319 | CMS |
| Amgen Inc. | $24.81 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117664321 | CMS |
| Amgen Inc. | $22.44 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117664323 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.31 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105461180 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.15 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105514397 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.28 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118149267 | CMS |
| GlaxoSmithKline, LLC. | $13.40 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116683003 | CMS |
| GlaxoSmithKline, LLC. | $16.38 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116054272 | CMS |
| Lundbeck LLC | $21.75 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146080272 | CMS |
| Novo Nordisk Inc | $23.07 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100641796 | CMS |
| Novo Nordisk Inc | $7.84 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100571456 | CMS |
| Novo Nordisk Inc | $19.30 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100539722 | CMS |
| Novo Nordisk Inc | $23.71 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100443041 | CMS |
| Novo Nordisk Inc | $19.65 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100471393 | CMS |
| Novo Nordisk Inc | $21.60 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100460910 | CMS |
| Novo Nordisk Inc | $25.06 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100609304 | CMS |
| Otsuka America Pharmaceutical, Inc. | $26.65 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119169800 | CMS |
| PFIZER INC. | $18.87 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131769526 | CMS |
| PFIZER INC. | $20.91 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131931884 | CMS |
| PFIZER INC. | $26.37 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131427491 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.